Two years after Gilead Sciences secured the first option on Assembly Biosciences’ entire pipeline, the pharma has decided to pick the first fruits from the pact. Gilead is paying $35 million upfront ...
In a note dated 27 February 2022, the Secretary-General informed Member States that the eleventh emergency special session would convene at Headquarters on Monday, 28 February 2022 for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback